Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Driving Business Growth in B2B Marketing: The Game-Changing Impact of the Creator Economy

B2B brands in the healthcare industry are increasingly leveraging creator economy partnerships to build credibility and drive revenue growth. The article explores how thought leaders and content creators can serve as strategic assets in crowded B2B marketplaces. Creator-led strategies are emerging as a differentiator for healthcare organizations seeking authentic audience engagement.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Experts Talk on MarketScale.

By Experts Talk · BlitzmetricsCreator EconomyDavid KempDennis Yu
Share

Key takeaways

01

B2B healthcare brands are partnering with creators to establish credibility in competitive markets.

02

The creator economy is reshaping how B2B companies approach demand generation and revenue growth.

03

Authentic creator content can accelerate trust-building with healthcare decision-makers and buyers.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Influencer marketing is no longer just for consumer brands. In a report titled Influencing Business: The Global Rise of B2B Influencer Marketing, Ogilvy estimates that the global market size has expanded over 20 times since 2016! And with the creator economy projected to reach $500 billion by 2027, businesses are taking note. Social platforms like YouTube, Instagram, and TikTok, boasting nearly 5 billion monthly active users, have fueled this rise of the creator economy. The question is, how can the B2B marketing sector leverage this trend to build trust and drive business impact?

And with the creator economy projected to reach $500 billion by 2027, businesses are taking note.

In the latest episode of Experts Talk, host Gabrielle Bejarano dives into this topic with guests David Kemp, Healthcare Lead at MarketScale, and Dennis Yu, CTO of BlitzMetrics. They explore the evolving landscape of influencer marketing and its growing importance in the B2B marketing sector.

Key discussion points include:

– The exponential growth and potential of influencer marketing in B2B.

– The importance of selecting credible influencers to build trust.

– How leveraging employee influencers can be a game-changer.

David Kemp's career spans from coaching college basketball to aiding major healthcare systems with ICD-10 transitions. Kemp now hosts the Highway to Health podcast series and leads the healthcare vertical at MarketScale.

Dennis Yu is the CEO of BlitzMetrics, a digital marketing company that collaborates with schools to train young adults in the field. He has extensive experience in managing high-profile campaigns for clients like The Golden State Warriors and Nike, and is also an internationally recognized lecturer who has spoken at over 730 events across 17 countries.

Experts Talk

Part of this channel

Experts Talk

Industry experts debate the ideas that drive B2B decisions.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

ET
Experts Talk

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

ET
Experts Talk

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512